Researchers have started to explore the potential for psilocybin, the psychedelic drug found in “magic” mushrooms, to treat obesity.

The UFC is looking to get involved with research into psychedelic drugs as a therapy for fighters’ brain health.

Mydecine announces a bought-deal financing with units priced at CAD$0.50.

MindMed’s new Chief Development Officer has over a decade of experience leading drug development programs.

Mydecine’s bought-deal financing is upsized by 50% to CAD $15 million.

Entheon acquires a genetic screening company to identify genetic markers that affect reactions to hallucinogenic drugs.

Core One Labs announces a research breakthrough to help improve consistency in psilocybin dosing.

ANN ARBOR – Washtenaw County Prosecutor Eli Savit announced Tuesday that his office will no longer bring charges in cases related to marijuana or entheogenic plant use, possession or small-scale distribution.

MindMed to Commence Groundbreaking LSD Microdosing Study Evaluating Benefits on Neuroplasticity, Sleep, Cognitive Enhancement Variables and Immune System Response on the Human Body 

Novamind Inc announces the expansion and optimization of its Cedar Psychiatry clinic in Utah.